Back to investors
HEALTHINVEST PARTNERS AB
HEALTHINVEST PARTNERS AB
Latest filing: 2026-06-30
HEALTHINVEST PARTNERS AB runs HEALTHINVEST PARTNERS AB and currently holds 39 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $371.70M. Their top holdings are LLY, MRK, JNJ, ABBV, CVS. The top five represent 30.4% of reported portfolio weight. HEALTHINVEST PARTNERS AB ranks #42 out of 1000 investors tracked by Alpha Score. In the most recent quarter, HEALTHINVEST PARTNERS AB initiated 3 new positions. They added to 14 existing positions. They trimmed 20 positions. Their current best-performing preview position is RVMD with returns of +612.21%.
Sign in to enable email alerts for this investor.
Showper page
39 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 LLY ELI LILLY & CO | 9.62% | $771.53 | $1,254.77 | +62.63% | Trimmed -24.93% |
 MRK MERCK & CO. INC | 6.55% | $124.61 | $152.52 | +22.40% | Added +459.35% |
 JNJ JOHNSON & JOHNSON | 5.84% | $244.44 | $270.30 | +10.58% | Trimmed -7.53% |
 ABBV ABBVIE INC | 4.35% | $184.92 | $265.01 | +43.31% | Trimmed -40.54% |
 CVS CVS HEALTH CORP | 4.07% | $99.53 | $93.02 | -6.55% | Added +514.57% |
 TMO THERMO FISHER SCIENTIFIC CORP | 3.76% | $531.39 | $629.12 | +18.39% | Added +21.20% |
 RVMD REVOLUTION MEDICINES INC | 3.68% | $89.42 | $209.46 | +134.24% | Trimmed -88.16% |
 BIIB BIOGEN INC | 3.65% | $216.06 | $216.78 | +0.33% | New Buy |
 NBIX NEUROCRINE BIOSCIENCES INC | 3.31% | $126.48 | $152.57 | +20.63% | Trimmed -18.72% |
 MIRM MIRUM PHARMACEUTICALS INC | 3.17% | $67.00 | $96.31 | +43.75% | Trimmed -48.51% |
Showing 1-10 of 39